Ахмеджанов Н. М., Бутрова С. А., Дедов И. И., Звенигородская Л. А., Кисляк О. А., Кошельская О. А., Кузнецова И. В., Кухарчук В. В., Литвин А. Ю., Медведева И. В., Мкртумян А. М., Мычка В. Б., Небиеридзе Д. В., Недогода С. В., Оганов Р. Г., Огарков М. Ю., Перепеч Н. Б., Подзолков В. И., Сметник В. П., Сусеков А. В., Титов В. Н., Тюрина Т. В., Фурсов А. Н., Хирманов В. Н., Чазова И. Е., Чукаева И. И., Шестакова М. В., Шубина А. Т. КОНСЕНСУС РОССИЙСКИХ ЭКСПЕРТОВ ПО ПРОБЛЕМЕ МЕТАБОЛИЧЕСКОГО СИНДРОМА В РОССИЙСКОЙ ФЕДЕРАЦИИ: ОПРЕДЕЛЕНИЕ, ДИАГНОСТИЧЕСКИЕ КРИТЕРИИ, ПЕРВИЧНАЯ ПРОФИЛАКТИКА И ЛЕЧЕНИЕ. Рациональная Фармакотерапия в Кардиологии. 2010;6(4):599-606.
https://doi.org/10.20996/1819-6446-2010-6-4-87-89
1. Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома. Кардиоваскулярная терапия и профилактика 2007;(5 приложение):5-32.
2. Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома (Второй пересмотр). Кардиоваскулярная терапия и профилактика 2009;(6 приложение 2):5-32
3. PurnelJ.Q., BrunzellJ.D. The centralrole of dietary fat, not carbohydrate, in the insulin resistans syndrome. Curr Opin Lipidol 1997;8(1):17-22.
4. Stevens J., Cai J., Pamuk E.R., et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338: 1-7.
5. Lapidus L., Bengtsson C., Larsson B. et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984; 289:1257-61.
6. Дедов И.И., Мельниченко Г.А. Ожирение. М.: Медицинское ин- формационное агентство, 2008.
7. Despres J.P., Moorjani S., Lupien P.J. et al. Regional distribution of body fat, plasma insulin, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
8. Sims E.A., Danforth E. Jr., Horton E.S. et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 1973;29:457-96.
9. Piatti P.M., Monti L.D., Pacchioni M. et al. Forearm insulin-and-non-insulin mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism 1991;40:926-33.
10. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A. The glucose-fatty acid cycle: its role in insulin sensitivity and metabolic disturbance of diabetes mellitus. Lancet 1963;1:785-9.
11. EvansD.J., Murrey R., KisselbahA.H. Relationship between skeletal muscles insulin resistance, insulin mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest 1984;74(4):1515-25.
12. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity — indused insulin resistance in mice lacking TNF alpha function. Nature 1997;389:610-4.
13. Dietschy J.M., Turley S.D., Spady D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993;34:1637-59.
14. Reaven G.M., Lithell H., Landsberg L.Hypertension and associated metabolic abnormalities — the role of insulin resistance and the sympatoadrenal system. N Engl J Med 1996;334:374-81.
15. Fraze E., Donner C.C., Swislocki A.L. et al. Ambient plasma free fatty acid concentration in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985;61:807-11.
16. Flier J.S. Leptin resistance and obesity. Presented at the 60th Scientific Sessions of the American Diabetes Association.June 13, 2000; San�Antonio, Texas.
17. Randle P.J., Priestman D.A., Mistry S.C., Halsall A. Glucose fatty acid interactions and the regulation of glucose disposal.JCell Biochem 1994;55 Suppl:1-11.
18. Ferrari P., Weidmann P. Insulin, insulin sensitivity and hypertension. J Hypertens 1990;8:491-500.
19. Defronzo R.A., Goldberg M., Agus Z.S. The effect of glucose and in�sulin on renal electrolyte transport. J Clin Invest 1976;58:83-90.
20. DeFronzo R.A., Cooke C.R., Andres R. et al. The effect of insulin in renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
21. Kamide K., Hori M.T., Zhu J.H. et al. Insulin-mediated growth in aortic smooth muscle and the vascular rennin-angiotensin system. Hypertension 1998;32:482-7.
22. Taddei S., Virdis A., Chiadoni L. et al. The pivotal role of endothelium in hypertension. Medicographia 1999;21:22-9.
23. Laakso M. Epidemiology of diabetic dislipidemia. Diabetes Rev 1995; 3:408-22.
24. Alberti K.G., Eckel R.H., Grundy S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
